Here we present a hydrophobic tissue clearing method that allows for the viewing of target molecules as part of intact brain structures. This technique has now been validated for F344/N control and HIV-1 transgenic rats of both sexes.
Method Article
Here we present a hydrophobic tissue clearing method that allows for the viewing of target molecules as part of intact brain structures. This technique has now been validated for F344/N control and HIV-1 transgenic rats of both sexes.
Hydrophobic tissue clearing methods are easily adjustable, fast, and low-cost procedures that allows for the study of a molecule of interest in unaltered tissue samples. Traditional immunolabeling procedures require cutting the sample into thin sections, which restricts the ability to label and examine intact structures. However, if brain tissue can remain intact during processing, structures and circuits can remain intact for the analysis. Previously established clearing methods take significant time to completely clear the tissue, and the harsh chemicals can often damage sensitive antibodies. The iDISCO method quickly and completely clears tissue, is compatible with many antibodies, and requires no special lab equipment. This technique was initially validated for the use in mice tissue, but the current protocol adapts this method to image hemispheres of control and transgenic rat brains. In addition to this, the present protocol also makes several adjustments to preexisting protocol to provide clearer images with less background staining. Antibodies for Iba-1 and tyrosine hydroxylase were validated in the HIV-1 transgenic rat and in F344/N control rats using the present hydrophobic tissue clearing method. The brain is an interwoven network, where structures work together more often than separately of one another. Analyzing the brain as a whole system as opposed to a combination of individual pieces is the greatest benefit of this whole brain clearing method.
Several tissue clearing techniques have been validated for the use in the brain: hydrogel, hydrophilic, and hydrophobic. These techniques aim to turn a tissue transparent through delipidation, decolorization, and decalcification via the administration of solvents. Once the refractive index of the tissue sample matches the refractive index of the chosen imaging medium, a clear image of the sample can be obtained. Hydrogel based techniques, such as CLARITY, secure biomolecules in the tissue by linking them to acryl-based hydrogels, which prevents structural damage and loss of proteins1. However, hydrogel techniques utilize harsh chemicals than ha....
Access restricted. Please log in or start a trial to view this content.
All animal protocols were reviewed and approved by the Animal Care and Use Committee at the University of South Carolina.
1. Stock solution preparation
Access restricted. Please log in or start a trial to view this content.
Full clearing of large sections of both F344/N and HIV-1 rat brain tissue was achieved using this modified hydrophobic tissue clearing protocol. Figure 1 displays a typical confocal image for TH in the substantia nigra region. Figure 1A represents dense, positive staining. Dense areas such as these can be parsed out by focusing through the āZā plane to confirm positive staining and proper cell morphology. Figure 1B represents sparse.......
Access restricted. Please log in or start a trial to view this content.
Tissue clearing offers a solution to the limitations of traditional IHC protocol. A sample that is transparent minimizes the scattering and absorption of light, which provides cellular level optical access to intact tissues18,19. Tissue clearing techniques turn a tissue transparent through delipidation, decolorization, and decalcification with the administration of solvents. Once the refractive index of the tissue sample matches the refractive index of the chosen.......
Access restricted. Please log in or start a trial to view this content.
None of the authors have conflicts of interest to declare.
This work was funded by NIH grants: NS100624, DA013137, HD043680, MH106392 & by T32 Training Grant 5T32GM081740
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Cholera Toxin Subunit B (Recombinant), Alexa Fluor 488 | Invitrogen | C34775 | |
| DBE | Sigma-Aldrich | 108014-1KG | |
| DCM | Sigma-Aldrich | 270997-100mL | |
| DMSO | Sigma-Aldrich | 472301-1L | |
| Glycine | Fisher Chemical | G46-500 | |
| Goat anti-rabbit Alexa Fluor Plus 647 | Invitrogen | A32733 | |
| Goat serum | Sigma Life Science | G9023-10mL | |
| Heparin | Acros Organics | 41121-0010 | |
| Iba1 primary antibody | FUJIFILM Wako | 019-19741 | |
| Kwik-sil epoxy | VWR | 70730-062 | |
| Methanol | Sigma-Aldrich | 34860-1l-R | |
| PBS | Fisher Bioreagents | BP2944-100 | |
| Perfusion machine | VWR | 70730-062 | mini pump variable flow |
| PFA | Sigma-Aldrich | 158127-3KG | |
| TH primary antibody | Millipore Sigma | AB152 | |
| TritonX-100 | Fisher Bioreagents | BP151-500 | |
| Tween-20 | Fisher Bioreagents | BP337-500 |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission